chartexchange

PEN
Penumbra, Inc.
stockNYSE

At CloseOct 2, 2026 3:59:50 PM EDT
317.59USD-0.129%(-0.41)239,681
Loading…
Loading…
Healthcare
Medical Devices
CEO
Adam Elsesser
HQ
Alameda, CA, USA
Previous Close
$318.00
Beta
0.02
52-Week High
$362.41 2026-01-21
52-Week Low
$221.26 2025-11-03
SMA 50
$321.62
SMA 200
$326.83
Avg. Vol 10D
356,134
Avg. Vol 30D
352,991
Avg. Vol 90D
364,252
Relative Vol
0.68
38.29M
1.1900%
Nov 4, 2026 (30d)
PEN Profile

penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.

PEN Performance
PeriodPriceDateChangeBeta
1W319.182026-09-28-0.46%-0.007
1M322.172026-09-04-1.38%0.147
3M318.232026-07-06-0.16%0.083
6M329.872026-04-06-3.69%0.082
1Y256.062025-10-03+24.08%0.016
2Y194.732024-10-04+63.16%—
5Y255.422021-10-04+24.39%0.965
PEN Stock Summary

Penumbra, Inc. (NYSE:PEN) stock price today is $317.72, and today's volume is 239,681. PEN is down 0.090% today. The 30 day average volume is 352,991. PEN market cap is $12.51B with 39.39M shares outstanding.